Archer Investment Corporation’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.6K Sell
53
-48
-48% -$17.1K ﹤0.01% 687
2025
Q4
$33.2K Sell
101
-99
-50% -$31.4K 0.01% 534
2025
Q3
$56.5K Buy
200
+1
+0.5% +$290 0.01% 468
2025
Q2
$55.6K Buy
199
+1
+0.5% +$283 0.01% 456
2025
Q1
$61.7K Buy
198
+1
+0.5% +$295 0.02% 437
2024
Q4
$51.4K Sell
197
-12
-6% -$3.56K 0.01% 434
2024
Q3
$67.4K Hold
209
0.02% 403
2024
Q2
$65.4K Buy
209
+6
+3% +$1.76K 0.02% 389
2024
Q1
$57.7K Hold
203
0.02% 397
2023
Q4
$58.5K Hold
203
0.02% 379
2023
Q3
$54.6K Hold
203
0.02% 371
2023
Q2
$45.1K Buy
203
+146
+256% +$33.9K 0.02% 395
2023
Q1
$13.8K Hold
57
0.01% 532
2022
Q4
$15K Hold
57
0.01% 503
2022
Q3
$12.8K Hold
57
0.01% 503
2022
Q2
$13.9K Sell
57
-421
-88% -$103K 0.01% 499
2022
Q1
$116K Buy
478
+134
+39% +$30.8K 0.04% 253
2021
Q4
$77.4K Buy
344
+13
+4% +$2.74K 0.03% 306
2021
Q3
$70.4K Hold
331
0.03% 309
2021
Q2
$80.7K Hold
331
0.03% 272
2021
Q1
$82.4K Buy
331
+287
+652% +$68.5K 0.03% 249
2020
Q4
$10.1K Hold
44
﹤0.01% 496
2020
Q3
$11.2K Hold
44
0.01% 437
2020
Q2
$10.4K Buy
+44
New +$10K 0.01% 428

Other funds holding AMGN

Archer Investment Corporation's AMGN Position: Q1 2026 in Review

Archer Investment Corporation reduced its Amgen (AMGN) stake by 48% in Q1 2026, selling an estimated $17.1K and leaving 53 shares worth $18.6K. The position accounts for ﹤0.01% of the portfolio, ranked #687.

Archer Investment Corporation first reported a position in AMGN in Q2 2020 and has held it in 24 quarters since. The position peaked at $116K in Q1 2022. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Archer Investment Corporation held 53 shares of Amgen worth $18.6K as of Q1 2026.
  • Archer Investment Corporation sold 48 Amgen shares in Q1 2026, an estimated $17.1K.
  • Amgen made up ﹤0.01% of Archer Investment Corporation's portfolio in Q1 2026, its #687 holding.
  • Archer Investment Corporation first reported a position in Amgen in Q2 2020 and has held it in 24 quarters since.
  • Archer Investment Corporation's Amgen position peaked at $116K in Q1 2022.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Archer Investment Corporation's 13F filing for Q1 2026, filed 4 May 2026.